INmune Bio
INMB
33 hedge funds and large institutions have $15.5M invested in INmune Bio in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 3
233% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 3
27% more funds holding
Funds holding: 26 → 33 (+7)
2.4% more ownership
Funds ownership: 6.35% → 8.75% (+2.4%)
3% more capital invested
Capital invested by funds: $15M → $15.5M (+$515K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.57M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.09M |
| 3 |
Millennium Management
New York
|
+$756K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$595K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$489K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$246K |
| 2 |
DC
Diametric Capital
Boston,
Massachusetts
|
-$215K |
| 3 |
VNA
Valley National Advisers
Bethlehem,
Pennsylvania
|
-$34K |
| 4 |
CAAS
Capital Asset Advisory Services
Williamston,
Michigan
|
-$32K |
| 5 |
Barclays
London,
United Kingdom
|
-$20.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CCM
26
Covington Capital Management
Los Angeles,
California
| $12K | – | – | – |
|
|
IAIM
27
International Assets Investment Management
Orlando,
Florida
| $12K | – | – | – |
|
|
ADL
28
Asset Dedication LLC
San Francisco,
California
| $10K | – | – | – |
|
|
SPIA
29
Steward Partners Investment Advisory
New York
| $5.94K | +$9K | +500 | New |
|
|
FDCDDQ
30
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $4.75K | -$7.2K | -400 | -50% |
|
|
IA
31
IFP Advisors
Tampa,
Florida
| $2K | +$3.31K | +184 | New |
|
32
Wells Fargo
San Francisco,
California
| $1K | +$216 | +12 | +30% |
|
|
PA
33
Parallel Advisors
San Francisco,
California
| $1K | +$1.8K | +100 | New |
|
|
DC
34
Diametric Capital
Boston,
Massachusetts
| – | -$215K | -12,470 | Closed |
|
|
VNA
35
Valley National Advisers
Bethlehem,
Pennsylvania
| – | -$34K | -2,000 | Closed |
|
|
CAAS
36
Capital Asset Advisory Services
Williamston,
Michigan
| – | -$32K | -1,875 | Closed |
|
INMB Hedge Fund Activity: Q1 2021 in Review
33 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q1 2021, worth a combined $15.5M — up 3.4% from $15M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new INMB positions and 3 closed out — a net gain of 7 holders — while 15 added to existing stakes and 3 trimmed.
The largest buyer was BlackRock, adding an estimated $3.57M. The largest seller was Bank of Montreal, cutting an estimated $246K.
- 33 institutional investors held INmune Bio (INMB) as of Q1 2021, up from 26 in Q4 2020.
- Funds reported $15.5M of INmune Bio stock for Q1 2021, up 3.4% quarter-over-quarter.
- 10 funds opened new INmune Bio positions in Q1 2021 and 3 closed out, a net change of +7 holders.
- The largest INmune Bio buyer in Q1 2021 was BlackRock, an estimated $3.57M added.
- The largest INmune Bio seller in Q1 2021 was Bank of Montreal, an estimated $246K sold.
Based on aggregated 13F filings for Q1 2021.